A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution

Military Medicine

Volumn 167, Issue 7, 2002, Pages 541-545

  Kahn, Qamar ^a   Ellis, Robert J ^a   Skikne, Barry S ^a   Mayo, Mathew S ^a   Allgood, John W ^a   Bodensteiner, David M ^a   Deauna Limayo, Delva ^a   Cook, James D ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ERUPTION; FEVER; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; RETROSPECTIVE STUDY; RIGOR; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0036066454     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/167.6.541     Document Type: Article

References (17)

1. Treatment of severe aplastic anemia with combined immunosuppression (antithymocyte globulin and high-dose methylprednisolone)
2. Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality
3. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: Comparison with bone marrow transplantation
4. Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy
5. Long-term outcome after marrow transplantation for severe aplastic anemia
6. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy. The European Group for Blood and Marrow Transplantation experience
7. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia
8. Antilymphocyte globulin, cyclosporin, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: An update of the GITMO/EBMT study on 100 patients
9. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine
10. Prospective randomized muticenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party
11. Aplastic anemia: The role of bone marrow transplantation
12. Therapy of aplastic anemia with sequential antithymocyte globulin and cyclosporin
13. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia
14. A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases
15. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation
16. Results of a randomized study of glycosylated rHuG-CSF lenograstim in severe aplastic anemia